Given the role of DR6 in axonal pruning during development, surprisingly but importantly, DR6 silencing in our in vivo model of ALS protected against the loss of MN cell bodies but was less effective in mitigating motor axon damage (Fig. 5). The gene discussed is TNFRSF21; the disease is amyotrophic lateral sclerosis.